Veeva Systems  logo
Veeva Systems VEEV
$ 179.11 -3.3%

Annual report 2026
added 03-20-2026

report update icon

Veeva Systems Financial Statements 2011-2026 | VEEV

Annual Financial Statements Veeva Systems

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

30.1 B 29.8 B 36.8 B 27.6 B 27.2 B 38.5 B 21 B 17.3 B 10.4 B 5.97 B 3.31 B 3.96 B 1.83 B - - -

Shares

164 M 162 M 161 M 155 M 153 M 151 M 148 M 144 M 140 M 136 M 132 M 128 M 51.7 M - - -

Historical Prices

184 184 229 178 178 255 272 141 89.3 55.3 40.7 28.9 26.4 32.1 - -

Net Income

909 M 714 M 526 M 488 M 427 M 380 M 301 M 230 M 142 M 68.8 M 54.5 M 40.4 M 23.6 M 18.8 M 4.23 M 3.91 M

Revenue

3.2 B 2.75 B 2.36 B 2.16 B 1.85 B 1.47 B 1.1 B 862 M 686 M 544 M 409 M 313 M 210 M 130 M 61.3 M 29.1 M

Cost of Revenue

782 M 700 M 677 M 609 M 504 M 409 M 303 M 245 M 211 M 174 M 142 M 116 M 82.6 M 57 M 29.1 M -

Gross Profit

2.41 B 2.05 B 1.69 B 1.55 B 1.35 B 1.06 B 801 M 617 M 474 M 370 M 267 M 198 M 128 M 72.5 M 32.2 M 16.8 M

Operating Income

916 M 691 M 429 M 459 M 505 M 378 M 286 M 223 M 158 M 121 M 78.6 M 70 M 39.3 M 30 M 6.64 M -

Interest Expense

278 M 228 M 159 M 50 M 6.82 M 16.2 M 27.5 M 15.8 M 7.84 M 1.67 M 28 K -2.78 M -804 K -940 K 15 K -

EBITDA

930 M 710 M 448 M 465 M 512 M 387 M 306 M 237 M 165 M 122 M 87.1 M 73.9 M 41.7 M 30.8 M 7.04 M 5.31 M

Operating Expenses

1.5 B 1.36 B 1.26 B 1.09 B 842 M 678 M 514 M 394 M 323 M 262 M 188 M 128 M 88.2 M 42.5 M 25.6 M 11.7 M

General and Administrative Expenses

301 M 266 M 247 M 218 M 172 M 149 M 114 M 86.4 M 60.4 M 48.8 M 41.5 M 30.2 M 20.4 M 8.37 M 5.54 M 2.51 M

All numbers in USD currency

Quarterly Income Statement Veeva Systems

2025-Q3 2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

164 M 163 M 163 M 162 M 162 M 161 M 161 M 160 M 160 M - 155 M 155 M 155 M - 154 M 153 M 152 M - 151 M 150 M 150 M - 148 M 148 M 147 M - 145 M 144 M 143 M - 141 M 140 M 137 M - 136 M 135 M 134 M 130 M 132 M 132 M 131 M 123 M 129 M 127 M 124 M 24.8 M 35.8 M 24.4 M 21.6 M - 20.7 M - - - - - -

Net Income

236 M 200 M 228 M 186 M 171 M 162 M 135 M 112 M 132 M - 108 M 90.6 M 100 M 103 M 106 M 109 M 116 M 66.2 M 97 M 93.6 M 86.6 M 71.2 M 82.2 M 79.2 M 73.4 M 40.7 M 64.1 M 50.3 M 44.3 M 21.7 M 34.9 M 38.6 M 37 M 17.6 M 21.6 M 13 M 12.5 M 13.3 M 10.5 M 13.4 M 13 M 6.25 M 10.3 M 9.58 M 7.22 M 5.68 M 6.52 M 6 M 4.84 M - 5.75 M 4.25 M 3.1 M - - - -

Revenue

811 M 789 M 759 M 699 M 676 M 650 M 617 M 590 M 526 M - 552 M 534 M 505 M 397 M 476 M 456 M 434 M 312 M 378 M 354 M 337 M 232 M 281 M 267 M 245 M 186 M 225 M 210 M 196 M 150 M 177 M 168 M 160 M 114 M 143 M 131 M 120 M 87 M 107 M 98.1 M 89.9 M 62.8 M 83.8 M 75.7 M 66.7 M 39.8 M 55 M 49.6 M 42.8 M - 35.8 M 29.5 M 24.5 M - - - -

Cost of Revenue

199 M 195 M 174 M 174 M 170 M 174 M 168 M 169 M 167 M - 154 M 152 M 140 M - 130 M 122 M 116 M - 103 M 97.2 M 94.9 M - 73.3 M 70.2 M 65.5 M - 61.4 M 59.2 M 60.2 M - 53.2 M 50.4 M 48.9 M - 43.9 M 42.2 M 41.1 M 31.2 M 37 M 33.5 M 32 M 24.4 M 30.4 M 28.1 M 26 M 16.8 M 21.4 M 19.1 M 17.7 M - 15.9 M 13 M 11.3 M - - - -

Gross Profit

612 M 594 M 585 M 525 M 506 M 476 M 449 M 421 M 360 M - 398 M 383 M 366 M 283 M 347 M 333 M 317 M 217 M 275 M 256 M 242 M 168 M 208 M 197 M 179 M 127 M 163 M 150 M 135 M 104 M 124 M 117 M 111 M 74.5 M 98.9 M 89.2 M 78.7 M 55.9 M 69.9 M 64.6 M 57.9 M 38.4 M 53.4 M 47.5 M 40.8 M 23 M 33.6 M 30.4 M 25.1 M - 19.9 M 16.4 M 13.2 M - - - -

Operating Income

241 M 196 M 234 M 181 M 166 M 155 M 128 M 104 M 61.5 M - 121 M 101 M 128 M 98.8 M 133 M 125 M 128 M 60.4 M 101 M 90.1 M 87.6 M 63 M 80.8 M 73.9 M 71.2 M 38.5 M 63.1 M 52.8 M 44 M 32.5 M 42.5 M 38.1 M 38.9 M 15.2 M 33.8 M 23.8 M 17.8 M 20.7 M 20.1 M 22.4 M 20.9 M 11.3 M 19.9 M 16.8 M 12.6 M 9.36 M 9.98 M 9.84 M 8.17 M - 8.78 M 7.12 M 4.76 M - - - -

Interest Expense

71.9 M 69.5 M 65.1 M 60.9 M 58.6 M 51.7 M 42.2 M 38.8 M 30.2 M - 12.5 M 8.4 M 2.71 M - 824 K 1.67 M 4.56 M - 3.46 M 2.88 M 3.41 M - 9.14 M 7.33 M 6.16 M - 4.61 M 3.34 M 2.14 M - 1.36 M 2.86 M 591 K - 525 K -1.36 M 2.75 M -1.66 M 110 K -445 K 763 K -365 K -989 K -101 K -30 K -603 K 125 K -65 K -499 K - 74 K -421 K 10 K - - - -

EBITDA

245 M 200 M 238 M 186 M 171 M 160 M 133 M 105 M 62.5 M - 122 M 103 M 130 M 98.8 M 135 M 127 M 130 M 60.4 M 103 M 92.1 M 89.6 M 63 M 86.4 M 79.4 M 76.6 M 38.5 M 66.5 M 56.3 M 47.6 M 32.5 M 46.1 M 41.6 M 42.3 M 15.2 M 37.3 M 27.3 M 21.2 M 20.7 M 22.6 M 23.7 M 21.9 M 11.3 M 21 M 17.8 M 13.5 M 9.36 M 10.8 M 10.3 M 8.44 M - 8.96 M 7.12 M 4.76 M - - - -

Operating Expenses

371 M 398 M 351 M 343 M 339 M 321 M 320 M 317 M 298 M - 277 M 281 M 238 M - 214 M 209 M 189 M - 173 M 166 M 155 M - 127 M 123 M 108 M - 100 M 97.6 M 91.4 M - 81.3 M 79.3 M 72 M - 65 M 65.3 M 60.9 M 35.2 M 49.8 M 42.3 M 37 M 27.1 M 33.5 M 30.7 M 28.2 M 13.7 M 23.6 M 20.6 M 16.9 M - 11.2 M 9.28 M 8.4 M - - - -

General and Administrative Expenses

68.5 M 95.8 M 68.8 M 72.4 M 61.4 M 61.3 M 62.3 M 62.9 M 62.7 M - 52.9 M 57.8 M 48.3 M - 42.8 M 42.2 M 41.2 M - 35.2 M 37.2 M 36.7 M - 28.7 M 25.9 M 23.5 M - 22.6 M 20.5 M 19.9 M - 15.4 M 14.6 M 13.6 M - 11.6 M 12.9 M 12.1 M 8.1 M 11.8 M 8.97 M 8.56 M 6.51 M 8.58 M 7.15 M 6.41 M 2.79 M 5.55 M 4.63 M 3.72 M - 2.24 M 1.81 M 1.54 M - - - -

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Veeva Systems VEEV
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Veeva Systems plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Health information services industry

Issuer Price % 24h Market Cap Country
Accolade Accolade
ACCD
- 0.29 % $ 206 M usaUSA
HealthStream HealthStream
HSTM
$ 20.97 -0.76 % $ 637 M usaUSA
Cerner Corporation Cerner Corporation
CERN
- - $ 27.9 B usaUSA
Change Healthcare Change Healthcare
CHNG
- - $ 9.03 B usaUSA
American Well Corporation American Well Corporation
AMWL
$ 5.76 -0.52 % $ 92.4 M usaUSA
Computer Programs and Systems Computer Programs and Systems
CPSI
- 4.4 % $ 133 M usaUSA
Covetrus Covetrus
CVET
- - $ 2.94 B usaUSA
Omnicell Omnicell
OMCL
$ 34.46 0.44 % $ 1.59 B usaUSA
iCAD iCAD
ICAD
- - $ 102 M usaUSA
Castlight Health, Inc. Castlight Health, Inc.
CSLT
- -7.28 % $ 227 M usaUSA
Phreesia Phreesia
PHR
$ 11.28 -4.41 % $ 615 M usaUSA
HMS Holdings Corp. HMS Holdings Corp.
HMSY
- - $ 3.29 B usaUSA
Inovalon Holdings, Inc. Inovalon Holdings, Inc.
INOV
- - $ 6.37 B usaUSA
HealthEquity HealthEquity
HQY
$ 82.1 0.56 % $ 7.07 B usaUSA
Evolent Health Evolent Health
EVH
$ 2.25 -9.64 % $ 211 M usaUSA
OptimizeRx Corporation OptimizeRx Corporation
OPRX
$ 6.78 5.44 % $ 116 M usaUSA
Schrödinger Schrödinger
SDGR
$ 11.57 -2.53 % $ 850 M usaUSA
MTBC MTBC
MTBC
- -0.58 % $ 51.7 M usaUSA
NextGen Healthcare NextGen Healthcare
NXGN
- - $ 1.6 B usaUSA
Teladoc Health Teladoc Health
TDOC
$ 5.42 -1.09 % $ 955 M usaUSA
GoodRx Holdings GoodRx Holdings
GDRX
$ 2.04 -1.92 % $ 787 M usaUSA
10x Genomics 10x Genomics
TXG
$ 19.81 3.5 % $ 2.32 B usaUSA
Premier Premier
PINC
- - $ 2.33 B usaUSA
R1 RCM R1 RCM
RCM
- - $ 3.81 B usaUSA
Akerna Corp. Akerna Corp.
KERN
- - $ 161 M usaUSA
Allscripts Healthcare Solutions Allscripts Healthcare Solutions
MDRX
- -10.39 % $ 886 M usaUSA
1Life Healthcare 1Life Healthcare
ONEM
- - $ 3.37 B usaUSA
Signify Health Signify Health
SGFY
- -0.02 % $ 7.21 B usaUSA
NantHealth NantHealth
NH
- -46.64 % $ 10.4 M usaUSA
Zhongchao Zhongchao
ZCMD
$ 1.81 -4.23 % $ 9.42 M chinaChina
Health Catalyst Health Catalyst
HCAT
$ 1.1 -9.5 % $ 76.9 M usaUSA
Streamline Health Solutions Streamline Health Solutions
STRM
- - $ 21.4 M usaUSA
SCWorx Corp. SCWorx Corp.
WORX
$ 0.13 -4.16 % $ 190 K usaUSA
Tabula Rasa HealthCare Tabula Rasa HealthCare
TRHC
- - $ 255 M usaUSA
Progyny Progyny
PGNY
$ 18.05 0.22 % $ 1.55 B usaUSA
So-Young International So-Young International
SY
$ 2.91 - $ 231 M chinaChina